动态18F-FDG PET/CT定量分析用于测量肺部炎症
研究纳入高纤维蛋白原(>2.8 g/l)的COPD受试者10例和从不吸烟的健康志愿者10例,行动态18F-FDG PET/CT,开发了校正肺内空气与血液的qABL定量方法,并与归一化Patlak分析比较。qABL法未检出全肺FDG组织代谢率在健康志愿者与COPD组间的差异,而归一化Patlak法检出显著差异,后者为受空气体积、血容量和肺组织实际FDG摄取共同影响的复合指标。
要点
- qABL法测得全肺FDG组织代谢率健康志愿者与COPD组间无差异(Hedge's g=0.15)。
- 归一化Patlak法测得全肺健康志愿者与COPD组间差异显著(Hedge's g=-1.59)。
- 归一化Patlak终点是受空气体积、血容量和肺组织实际FDG摄取影响的复合指标。
核心结论
- 作者引入了一种可直接估计肺组织FDG代谢率的定量分析方法,有助于理解疾病组肺部18F-FDG信号的来源并解读标准或新型治疗后的变化。
研究设计与样本
- 研究比较高纤维蛋白原(>2.8 g/l)COPD受试者(N=10)与从不吸烟健康志愿者(N=10)的动态18F-FDG PET/CT。
- 采用共配准CT图像分割肺并半自动定义上、中、下亚区,开发了校正肺内空气与血液的qABL定量方法,同时进行归一化Patlak分析以便与既往发表结果比较。
- 采用Hedge's g效应量比较健康志愿者与COPD组。
主要发现
- qABL法测得全肺FDG组织代谢率健康志愿者(μ=6.0±1.9×10-3 ml cm-3 min-1)与COPD组(μ=5.7±1.7×10-3 ml cm-3 min-1)间无差异(Hedge's g=0.15 [-0.76 1.04])。
- 归一化Patlak法测得全肺健康志愿者(μ=2.9±0.5×10-3 ml cm-3 min-1)与COPD组(μ=3.9±0.7×10-3 ml cm-3 min-1)间差异显著(Hedge's g=-1.59 [-2.57 -0.48])。
- 归一化Patlak终点被证明是受空气体积、血容量和肺组织实际18F-FDG摄取共同影响的复合指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An inflammatory reaction in the airways and lung parenchyma, comprised mainly of neutrophils and alveolar macrophages, is present in some patients with chronic obstructive pulmonary disease (COPD). Thoracic fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) has been proposed as a promising imaging biomarker to assess this inflammation. We sought to introduce a fully quantitative analysis method and compare this with previously published studies based on the Patlak approach using a dataset comprising 18F-FDG PET scans from COPD subjects with elevated circulating inflammatory markers (fibrinogen) and matched healthy volunteers (HV). Dynamic 18F-FDG PET scans were obtained for high-fibrinogen (>2.8 g/l) COPD subjects (N = 10) and never smoking HV (N = 10). Lungs were segmented using co-registered computed tomography images and subregions (upper, middle and lower) were semi-automatically defined. A quantitative analysis approach was developed, which corrects for the presence of air and blood in the lung (qABL method), enabling direct estimation of the metabolic rate of FDG in lung tissue. A normalised Patlak analysis approach was also performed to enable comparison with previously published results. Effect sizes (Hedge's g) were used to compare HV and COPD groups. RESULTS: The qABL method detected no difference (Hedge's g = 0.15 [-0.76 1.04]) in the tissue metabolic rate of FDG in the whole lung between HV (μ = 6.0 ± 1.9 × 10-3 ml cm-3 min-1) and COPD (μ = 5.7 ± 1.7 × 10-3 ml cm-3 min-1). However, analysis with the normalised Patlak approach detected a significant difference (Hedge's g = -1.59 [-2.57 -0.48]) in whole lung between HV (μ = 2.9 ± 0.5 × 10-3 ml cm-3 min-1) and COPD (μ = 3.9 ± 0.7 × 10-3 ml cm-3 min-1). The normalised Patlak endpoint was shown to be a composite measure influenced by air volume, blood volume and actual uptake of 18F-FDG in lung tissue. CONCLUSIONS: We have introduced a quantitative analysis method that provides a direct estimate of the metabolic rate of FDG in lung tissue. This work provides further understanding of the underlying origin of the 18F-FDG signal in the lung in disease groups and helps interpreting changes following standard or novel therapies.
引用
- Coello C, Fisk M, Mohan D, et al. Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation. EJNMMI Res. 2017. PMID: 28547129. doi:10.1186/s13550-017-0291-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。